Can This Tiny Biotech Take On Pfizer?

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Sep 20, 2022 at 10:32 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,057
    Likes Received:
    3
    via
    • Prometheus Biosciences and Pfizer are both developing experimental first-of-their-kind treatments for inflammatory bowel disease.
    • Inflammatory bowel disease candidates from Pfizer and Prometheus Biosciences are similar, but there are a couple of key differences.
    • Prometheus Biosciences' stock price could skyrocket this year if its candidate outperforms Pfizer's candidate.

    article source